The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJDS.L Regulatory News (JDS)

  • There is currently no data for JDS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update Review:Long-term Strategic Options for EXHK

27 Sep 2017 07:31

RNS Number : 9335R
Mandarin Oriental International Ltd
27 September 2017
 

To: Business Editor For immediate release

 

This announcement contains Inside Information.

 

MANDARIN ORIENTAL - UPDATE TO REVIEW OF LONG-TERM STRATEGIC OPTIONS FOR THE EXCELSIOR, HONG KONG

 

27th September 2017 - Mandarin Oriental International Limited (the 'Company') today announced that having considered the proposals recently received for the sale of The Excelsior, Hong Kong, none had met fully its expectations or transaction requirements. As the proposals have not provided the basis for the sale of the property at the current time, the Company is continuing to review all options, including those that may result in redevelopment of the property into a commercial building.

 

The Company had announced previously that as part of a review of its long-term strategic options for The Excelsior it was to test market interest in the possible sale of the property. On 15th September 2017, the Company advised that it had received proposals from potential purchasers to acquire the property, and that these proposals would form the basis for further consideration of the Company's strategic options.

 

A further announcement will be made as required.

 

Mandarin Oriental currently operates 30 hotels and eight residences in 20 countries and territories. The Group's hotels are all five star luxury properties, with the exception of The Excelsior, Hong Kong which is a leading four star hotel. It also has a strong pipeline of hotels and residences under development. Mandarin Oriental International Limited is incorporated in Bermuda and has a standard listing on the London Stock Exchange, with secondary listings in Bermuda and Singapore. It is a member of the Jardine Matheson Group.

 

- end -

 

For further information, please contact:

 

Brunswick Group Limited

Joanna Donne (852) 9221 3930

Karin Wong (852) 9755 6265

Tom Burns (44) 20 7396 5308

 

This and other Group announcements can be accessed through the internet at 'www.mandarinoriental.com'.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
UPDZMGZLVNLGNZG
Date   Source Headline
23rd Jan 201910:38 amRNSShares Purchase
22nd Jan 201910:48 amRNSShares Purchase
21st Jan 201911:21 amRNSShares Purchase
20th Dec 201811:34 amRNSDirector Declaration
17th Dec 20187:00 amRNSDF Increases Interest in Rose Pharmacy Inc to 100%
23rd Nov 20189:10 amRNSDF Completes Partnership with Robinsons in Phl
8th Nov 20189:20 amRNSInterim Management Statement
8th Nov 20189:17 amRNSInterim Management Statement
8th Nov 20189:12 amRNSInterim Management Statement
8th Nov 20189:12 amRNSInterim Management Statement
8th Nov 20189:10 amRNSInterim Management Statement
7th Nov 20189:21 amRNS2018 Third Quarter Financial Statements
31st Oct 20189:12 amRNSTotal Voting Rights
30th Oct 201810:02 amRNSNine Months 2018 Results of PT Hero
29th Oct 20187:00 amRNSPT Astra 2018 Third Quarter Financial Statements
12th Oct 201812:00 pmRNSShares Purchase
10th Oct 201810:45 amRNSShares Purchase
10th Oct 201810:12 amRNSDirector/PDMR Shareholding
9th Oct 201811:03 amRNSShares Purchase
5th Oct 201810:47 amRNSShares Purchase
5th Oct 201810:36 amRNSAdditional Listing
4th Oct 201811:30 amRNSShares Purchase
3rd Oct 201811:14 amRNSShares Purchase
2nd Oct 201811:36 amRNSShares Purchase
2nd Oct 20187:00 amRNSDF Increases Interest in Rose Pharmacy Inc to 100%
1st Oct 20187:00 amRNSDirectorate Change
1st Oct 20187:00 amRNSDirectorate Change
1st Oct 20187:00 amRNSDirectorate Change
1st Oct 20187:00 amRNSDirectorate Change
1st Oct 20187:00 amRNSDirectorate Change
26th Sep 201810:10 amRNSDividend
21st Sep 201811:33 amRNSDividend
29th Aug 201810:08 amRNSCirc re. Scrip Dividend Scheme
17th Aug 201810:26 amRNSDF Partnership With Robinsons Receive PCC Approval
27th Jul 201810:47 amRNSHalf-year Report
27th Jul 201810:41 amRNSHalf-year Report
26th Jul 201811:07 amRNSPT Astra International Tbk Half Year Report
26th Jul 201810:06 amRNSHalf-year Report
26th Jul 201810:06 amRNSHalf-year Report
26th Jul 201810:06 amRNSHalf-year Report
25th Jul 201810:35 amRNSFirst Half of 2018 Results of PT Hero
28th Jun 201810:11 amRNSNotice of 2018 Half-Yearly Results
7th Jun 20187:00 amRNSMandarin Oriental International Ltd Announcement
31st May 201810:25 amRNSTotal Voting Rights
16th May 201810:14 amRNSDirector/PDMR Shareholding
11th May 201810:10 amRNSAdditional Listing
10th May 20185:06 pmRNSDirectorate Change
10th May 20185:05 pmRNSResult of AGM
10th May 20185:05 pmRNSNon-Routine Resolutions submitted via NSM
10th May 201812:34 pmRNSInterim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.